Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07316257

Value of Adding T2 Mapping Routine MRI in Assessment of Knee Articular Cartilage Early Osteoarthritis

This work aims at elucidating the role of MRI complementary T2 mapping in assessment of the articular knee cartilage for improving sensitivity of detection of early stage of osteoarthritis

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Observational

About this study

Osteoarthritis (OA) is one of the most common degenerative joint diseases, affecting more than 500 million people worldwide (1), causing joint pain and stiffness, and negatively affecting quality of life . The knee is the most commonly affected joint, followed by the hand and hip (1).

It is important clinically to diagnose osteoarthritis in its early stages to prevent its inevitable progression (2) Routine MR imaging sequences used in the identification of knee osteoarthritis can assess articular cartilage morphology, but despite its accuracy for identifying deep hyaline cartilage defects which are considered irreversible cartilage degeneration with limited treatment options, it lacks sufficient sensitivity for early cartilage changes and low-grade chondral lesions which are the reversible stages for the potential alteration of the osteoarthritis progression(2).

T2 mapping of hyaline cartilage is an imaging technique for the qualitative and quantitative detection of the cartilage providing convincing color mapping and quantitative detection of the cartilage mainly regarding architecture and changes in water content, proteoglycan, and collagen matrix ultra-structure associated with early cartilage degeneration(3).

T2 mapping is a time constant describing the rate at which energy transfer occurs between water protons in a magnetic field (spin-spin interactions), leading to signal dephasing. In normal healthy articular cartilage, water protons are largely bound in place by a well-organized matrix of collagen fibers, allowing for rapid dephasing, and therefore low T2 values are seen(4). However, in osteoarthritic articular cartilage, the collagen fibers become disorganized, and there are more mobile water protons, resulting in high T2 values. (4).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with clinical evidence of osteoarthritis

Exclusion criteria

  • • contraindications for MRI such as claustrophobia, heart pacemaker and ferromagnetic implants
  • patients in which the misaligned images or distortions due to motion artifacts made the interpretation of the MRI unreliable.
  • Patients with previous knee operation

Treatment and study plan

MRI

Device

Device that use coil to image asses the articular cartilage of the knee

Primary outcomes

  1. This work aims at elucidating the role of MRI complementary T2 mapping to measure the changes in T2 relaxation time of the articular knee cartilage in healthy group which there number will be 28 and pateints with early osteoarthritis there number 28

    Time frame: baseline

    to detect the value of adding T2 mapping to routine MRI in assessment of the articular cartilage in knee osteoarthritis

Secondary outcomes

  1. This work aims at quantitive stratification of osteoarthrtic changes and its impact on treatement

    Time frame: baseline

    to detect the value of adding T2 mapping to routine MRI in assessment of knee articular cartilage in knee osteoarthritis

Study contacts

Contact information is provided by the study sponsor or research team.

Shrouk Mohamed Gad, MSC

CONTACT

[email protected]

+201028565525

zahraa sayed hassan, MD

CONTACT

[email protected]

+201026816205

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Value of Adding T2mapping Sequence to Routine MRI Protocol in Assessment of Knee Articular Cartilage in Early Osteoarthritis

Acronym: T2 mapping OS

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jan 5, 2026
Registry last updated
Jan 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.